“Whether it’s understanding predisposition for diseases, diagnosing people with diseases, treating them, choosing gene therapies — we are at the cusp of genomics really entering the mainstream of the clinic.”
Francis deSouza is the CEO and President of Illumina, a global leader in DNA sequencing and array-based technologies. Under his leadership, Illumina is driving adoption of genomic sequencing to unlock the power of the genome and improve human health. DeSouza is currently responsible for directing all aspects of company strategy, planning and operations, and previously led the company’s business units and core functions responsible for envisioning, developing, and producing its products.
Prior to joining Illumina, deSouza held the roles of President, Products and Services, and Senior Vice President, Enterprise Security Group, at Symantec, where he was responsible for driving the vision for the company’s marketing-leading portfolio. He previously founded the technology companies Flash Communications (acquired by Microsoft) and IMlogic (acquired by Symantec).
DeSouza has been named one of Glassdoor’s Top 100 CEOs, Silicon Valley Business Journal’s Silicon Valley 40 Under 40, Fast Company’s Fast 50 Champion of Innovation, and a Fortune Businessperson of the Year. He is currently a member of the Board of Directors of The Walt Disney Corporation.
He earned his B.S. and M.S. in electrical engineering and computer science from MIT before later joining IBM, Microsoft, and Symantec.